Differin XP

Galderma was hoping to launch Differin XP in 2005, but delays from the FDA may move things back until late 2006.

This new formulation of Differin is a new offering to the topical retinoids. The 0.3% strength Differin XP has been proven in studies to be more effective at both reducing total lesion counts as well as reductions in both inflammatory (pimples and pustules) and non-inflammatory (blackheads and whiteheads) lesions than Differin 0.1% gel.

We will see where this fits in among other topical retinoids and look forward to possible head to head studies with Retin-a and Tazorac.

Add comment February 11th, 2006